Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001859 · ClinicalTrials.gov registry record
Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
A clinical trial of Diabetes Mellitus and Kidney Failure, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 621
- Enrollment target
- 1
- Study location
NCT00001859 is a study of Diabetes Mellitus and Kidney Failure that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 621 participants, below the 1,864-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001859, a study of Diabetes Mellitus and Kidney Failure, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 621 participants
- Enrollment target
- 1
- Study location
Study Summary
Kidney transplantation is the preferred treatment for most end-stage kidney disease. This procedure is limited, however, by two major factors: 1) a shortage of donor organs and 2) organ rejection by the recipient. The National Institute of Diabetes and Digestive and Kidney Diseases is screening patients with kidney failure or diabetes who may be eligible for kidney, kidney and pancreas, or islet cell transplantation. Patients in this screening study are not offered treatment. When the screening is complete, patients will be offered an opportunity to participate in another institute study, or, if there are no active studies appropriate for the patient, other options will be suggested to the primary or referring physician. Patients found eligible for a study are not obligated to participate. Screening for all patients typically consists of blood tests, urinalysis, electrocardiogram, PPD tuberculosis screen and pregnancy test. Chest and kidney X-rays and other studies may be done on patients determined eligible for a particular study, including transplantation. A summary of all test results will be sent to the referring physician unless the patient requests otherwise. ...
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 1999-06-04 |
| Est. Completion | 2014-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001859
The ClinicalTrials.gov registry entry for NCT00001859 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 621 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,864-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (67% lower). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT00001859 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001859 about?
NCT00001859 is a clinical study titled "Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant". Kidney transplantation is the preferred treatment for most end-stage kidney disease. This procedure is limited, however, by two major factors: 1) a shortage of donor organs and 2) organ rejection by the recipient. The National Institute of Diabetes and Digestive and Kidney Diseases is screening pati...
What is the current status of trial NCT00001859?
This trial is currently completed. The enrollment target is 621 participants. The study started on 1999-06-04. Estimated completion is 2014-05-30.
What conditions does trial NCT00001859 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Kidney Failure.
Who is sponsoring clinical trial NCT00001859?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001859 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.